Simultaneous PET/MR imaging has been successfully implemented for whole-body staging of numerous tumor entities within the last four years. However, to date, the introduced study protocols were acquainted with prolonged examination times, potentially impeding patient comfort and patient compliance. The present results demonstrate the high diagnostic capability of integrated PET/MR imaging for staging patients with suspected breast cancer recurrence. Furthermore, facing the need for an optimization of dedicated MR study protocols for whole-body PET/MR imaging on oncological purposes, the present data support the application of fast, yet morphologically adequate PET/MR protocols, leaving the application of contrast-agent and DWI debatable.
This abstract and the presentation materials are available to members only; a login is required.